Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection, Subcutaneous injection
Vaccine group: 
All people aged ≥6 months

Registered for use in people aged ≥6 months.

Quadrivalent inactivated influenza vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 15 µg haemagglutinin of each of the 4 recommended influenza virus strains

Also contains traces of:

  • ovalbumin (≤ 0.05 µg) 
  • neomycin (≤ 10.1 pg)
  • formaldehyde (≤ 30 µg)
  • octoxinol-9 (≤ 222.5 µg)
Related diseases: 
Influenza (flu)

Page history

Last updated: 
9 April 2020
Last reviewed: 
9 April 2020